-
Mashup Score: 1Data-Driven Insights | 20 Years of FDA Leadership in Novel Cancer Drug Approvals - Friends of Cancer Research - 10 day(s) ago
Authors: Bhaavna Yalavarthi1 and Grace Collins2 In 2011, Friends published a study in Health Affairs that challenged the prevailing narrative of the time, which suggested that the U.S. Food and Drug Administration (FDA) was slower and less efficient than other regulatory authorities, such as the European Medicines Agency (EMA). This study provided evidence to the…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 5Meeting Recap | Advancing the Future of Diagnostics and Regulatory Innovations - Friends of Cancer Research - 10 day(s) ago
On February 4th, Friends of Cancer Research (Friends) hosted a public meeting, “Advancing the Future of Diagnostics and Regulatory Innovations,” emphasizing the dual objectives of ensuring patient safety while fostering an environment conducive to innovation—a balance that is becoming increasingly critical in an era marked by rapid technological advancements. https://youtube.com/watch?v=wFHolEBYx48%3Fsi%3DCk6uqqepK_R4KsxA Key Takeaways & Helpful Resources…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Oncologists1Tweet-
As AI evolves in healthcare, regulatory science has to guide responsible adoption. #FriendsDx explored how oversight shapes #AI, digital pathology, & CDx for rare biomarkers, ensuring innovation expands access while ensuring patient safety. Read the recap: https://t.co/5nzlgqcOVB https://t.co/iHVcfvZNjY
-
-
Mashup Score: 2Policy Priorities - Friends of Cancer Research - 13 day(s) ago
Friends of Cancer Research Policy Portfolio Friends of Cancer Research (Friends) fosters collaboration among leaders from federal health and regulatory agencies, academia, the private sector, and patient advocacy groups to identify and address critical issues in development of new oncology drugs. By bringing together diverse perspectives, Friends proposes unique approaches to solve current challenges in…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Oncologists1Tweet-
Interested in learning more about AI, diagnostics, and regulatory science as discussed in Session 3? Explore our newly launched Policy Priorities Page: https://t.co/OHhCIt7vB3. #FriendDx
-
-
Mashup Score: 4Advancing the Future of Diagnostics and Regulatory Innovations - Friends of Cancer Research - 14 day(s) ago
Advancing the Future of Diagnostics and Regulatory Innovations Tuesday, February 4, 2025 10AM – 2PM ET The Ritz Carlton 1150 22nd St NW, Washington, DC 20037 Conference will also be streamed virtually Register Today Friends of Cancer Research (Friends) is hosting a meeting focused on driving forward innovation in diagnostics and regulatory policy. Discussions…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Oncologists1Tweet-
Our partnership aims to inform the development of best practices for measuring and reporting AI-driven biomarker assessments in drug development to better understand variability across AI models. Full findings will be presented at our Feb 4th meeting. https://t.co/xP0mEHpy4k https://t.co/wcOUFZwnLO
-
-
Mashup Score: 4
Friends of Cancer Research (Friends) is hosting a webinar designed for advocates on February 19, 2025. The webinar, “Advancing the Future of Diagnostics and Regulatory Innovations Meeting Recap: Sharing Next Steps and Opportunities with Advocates,” will dive into the discussions from the core event and explore implications for patient advocacy and regulatory efforts.
Source: friendsofcancerresearch.orgCategories: General Medicine News, Oncologists1Tweet-
Patient Advocates: Join our patient-focused webinar on 2/19 that will dive into discussions, topics, and implications from the Advancing the Future of Diagnostics and Regulatory Innovations meeting. Register today: https://t.co/jtLGhotRgp https://t.co/MFq5eisRne
-
-
Mashup Score: 5Friends Announces Janet Woodcock and Paul Kim’s Appointment to Board of Directors - Friends of Cancer Research - 27 day(s) ago
Washington, DC – Friends of Cancer Research (Friends) is excited to announce the addition of Dr. Janet Woodcock, Former Director of the Center for Drug Evaluation and Research (CDER) at the U.S. Food and Drug Administration (FDA) and Paul Kim, Principal of Kendall Square Policy Strategies LLC, to its Board of Directors. Dr. Janet Woodcock…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Oncologists1Tweet-
Friends welcomes Paul Kim to its Board of Directors. Kim brings a wealth of knowledge in federal life sciences and public health policy and has been integral in informing and shaping public health in the US. https://t.co/9HsZ25uOAz https://t.co/9TyIEEoiZz
-
-
Mashup Score: 4Advancing the Future of Diagnostics and Regulatory Innovations - Friends of Cancer Research - 1 month(s) ago
Advancing the Future of Diagnostics and Regulatory Innovations Tuesday, February 4, 2025 10AM – 2PM ET The Ritz Carlton 1150 22nd St NW, Washington, DC 20037 Conference will also be streamed virtually Register Today Friends of Cancer Research (Friends) is hosting a meeting focused on driving forward innovation in diagnostics and regulatory policy. Discussions…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Oncologists1Tweet-
Our partnership aims to inform the development of best practices for measuring and reporting AI-driven biomarker assessments in drug development to better understand variability across AI models. Full findings will be presented at our Feb 4th meeting. https://t.co/xP0mEHpy4k https://t.co/wcOUFZwnLO
-
-
Mashup Score: 4Advancing the Future of Diagnostics and Regulatory Innovations - Friends of Cancer Research - 1 month(s) ago
Advancing the Future of Diagnostics and Regulatory Innovations Tuesday, February 4, 2025 10AM – 2PM ET The Ritz Carlton 1150 22nd St NW, Washington, DC 20037 Conference will also be streamed virtually Register Today Friends of Cancer Research (Friends) is hosting a meeting focused on driving forward innovation in diagnostics and regulatory policy. Discussions…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Oncologists1Tweet-
Our partnership aims to inform the development of best practices for measuring and reporting AI-driven biomarker assessments in drug development to better understand variability across AI models. Full findings will be presented at our Feb 4th meeting. https://t.co/xP0mEHpy4k https://t.co/wcOUFZwnLO
-
-
Mashup Score: 4Advancing the Future of Diagnostics and Regulatory Innovations - Friends of Cancer Research - 2 month(s) ago
Advancing the Future of Diagnostics and Regulatory Innovations Tuesday, February 4, 2025 10AM – 2PM ET The Ritz Carlton 1150 22nd St NW, Washington, DC 20037 Conference will also be streamed virtually Register Today Friends of Cancer Research (Friends) is hosting a meeting focused on driving forward innovation in diagnostics and regulatory policy. Discussions…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Oncologists1Tweet-
Our partnership aims to inform the development of best practices for measuring and reporting AI-driven biomarker assessments in drug development to better understand variability across AI models. Full findings will be presented at our Feb 4th meeting. https://t.co/xP0mEHpy4k https://t.co/wcOUFZwnLO
-
-
Mashup Score: 4Advancing the Future of Diagnostics and Regulatory Innovations - Friends of Cancer Research - 2 month(s) ago
Advancing the Future of Diagnostics and Regulatory Innovations Tuesday, February 4, 2025 10AM – 2PM ET The Ritz Carlton 1150 22nd St NW, Washington, DC 20037 Conference will also be streamed virtually Register Today Friends of Cancer Research (Friends) is hosting a meeting focused on driving forward innovation in diagnostics and regulatory policy. Discussions…
Source: friendsofcancerresearch.orgCategories: General Medicine News, Oncologists1Tweet-
Our partnership aims to inform the development of best practices for measuring and reporting AI-driven biomarker assessments in drug development to better understand variability across AI models. Full findings will be presented at our Feb 4th meeting. https://t.co/xP0mEHpy4k https://t.co/wcOUFZwnLO
-
New Study: @US_FDA leads the world in approving novel #oncology drugs, reviewing almost twice as fast as the EMA and ensuring faster #patientaccess to lifesaving treatments. Read our latest blog post for the full findings: https://t.co/D4dBC2Qavi https://t.co/Rj8aGV1dfn